Key result
Among patients with newly diagnosed atrial fibrillation at high risk for stroke, only 41.3% received an oral anticoagulant prescription within 6 months.
Why the study?
Although oral anticoagulants reduce stroke risk in atrial fibrillation, many patients do not receive therapy, prompting evaluation of high-risk patients left untreated and factors linked to prescribing.
What factors are associated with oral anticoagulant prescription within 6 months of a new atrial fibrillation diagnosis?
Population
18 404 patients with a new diagnosis of AF
Comparison
Factors associated with receiving vs not receiving an OAC prescription
Design
Retrospective study
Follow-up
6 months
Authors
Loading...
Under-prescription of oral anticoagulants remains common in high-risk AF; leaves open barriers to uptake and effects on outcomes.
Observational (n=18,404)
What factors are associated with oral anticoagulant prescription within 6 months of a new atrial fibrillation diagnosis?
A significant proportion of newly diagnosed AF patients at high stroke risk do not receive timely OAC prescription, with disparities based on sex, race, and comorbidities.
Manning et al. (2023) conducted an observational in Atrial fibrillation (n=18,404). Patient characteristics and stroke risk was evaluated on Prescription of an oral anticoagulant within 6 months following diagnosis. Among patients with newly diagnosed atrial fibrillation at high risk for stroke, only 41.3% received an oral anticoagulant prescription within 6 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: